United States · FDA National Drug Code directory
Metolazone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-285_875c85ff-ca13-41b1-bc4e-ca871c3d2cd1
- Product NDC
- 71610-285
- Form
- TABLET
- Composition / generic term
- Metolazone
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20031219
- Source listing expiry
- 20261231
Source-listed ingredients
- METOLAZONE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9000 TABLET in 1 BOTTLE (71610-285-09) · 71610-285-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →